Cargando…

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

BACKGROUND: The purpose of this study was to investigate the suitability of nanostructured lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment of breast cancer. METHODS: HePC-NLCs were prepared using a microemulsion technique and then evaluated for particle s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Guo, Ali, Zakir, Sajjad Khan, Anam, Ullah, Kalim, Jamshaid, Humzah, Zeb, Alam, Imran, Muhammad, Sarwar, Sadia, Choi, Han-Gon, ud Din, Fakhar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127833/ https://www.ncbi.nlm.nih.gov/pubmed/34012260 http://dx.doi.org/10.2147/IJN.S299443

Ejemplares similares

Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
por: Ali, Zakir, et al.
Publicado: (2022)

Diagnostic and Treatment Strategies for COVID-19
por: Jamshaid, Humzah, et al.
Publicado: (2020)

Retraction Note: Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
por: Ali, Zakir, et al.
Publicado: (2023)

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers [Retraction]
Publicado: (2023)

Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight
por: Jamshaid, Humzah, et al.
Publicado: (2021)

Metformin HCl-loaded transethosomal gel; development, characterization, and antidiabetic potential evaluation in the diabetes-induced rat model
por: Nousheen, Kainat, et al.
Publicado: (2023)

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
por: Jamshaid, Humzah, et al.
Publicado: (2022)

Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
por: Din, Fakhar ud, et al.
Publicado: (2017)

Augmented Oral Bioavailability and Prokinetic Activity of Levosulpiride Delivered in Nanostructured Lipid Carriers
por: Arif, Sadia Tabassam, et al.
Publicado: (2022)

Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis
por: Castro, María del Mar, et al.
Publicado: (2017)

No evidence for cardiotoxicity of miltefosine()
por: Dorlo, Thomas P.C.
Publicado: (2022)

Particle and Gel Characterization of Irinotecan-Loaded Double-Reverse Thermosensitive Hydrogel
por: Din, Fakhar ud, et al.
Publicado: (2021)

Antitumor and anti-angiogenic potentials of isolated crude saponins and various fractions of Rumex hastatus D. Don.
por: Ahmad, Sajjad, et al.
Publicado: (2016)

Melatonin delivered in solid lipid nanoparticles ameliorated its neuroprotective effects in cerebral ischemia
por: Sohail, Saba, et al.
Publicado: (2023)

No evidence for cardiotoxicity of miltefosine – Reply()
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

Investigation of the treatment potential of Raloxifene-loaded polymeric nanoparticles in osteoporosis: In-vitro and in-vivo analyses
por: Guo, Zhonghua, et al.
Publicado: (2023)

In Vitro and Ex Vivo Evaluation of Fluocinolone Acetonide–Acitretin-Coloaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis
por: Raza, Hassan, et al.
Publicado: (2022)

Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect
por: Bashir, Sidra, et al.
Publicado: (2023)

Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol
por: Gonçalves, Gustavo, et al.
Publicado: (2021)

Enhanced Antidepressant Activity of Nanostructured Lipid Carriers Containing Levosulpiride in Behavioral Despair Tests in Mice
por: Arif, Sadia Tabassam, et al.
Publicado: (2023)

Oral miltefosine for refractory Acanthamoeba keratitis
por: Hirabayashi, Kristin E., et al.
Publicado: (2019)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition
por: Bulté, Dimitri, et al.
Publicado: (2021)

Cisplatin and oleanolic acid Co-loaded pH-sensitive CaCO(3) nanoparticles for synergistic chemotherapy
por: Khan, Muhammad Waseem, et al.
Publicado: (2022)

Leishmania Resistance to Miltefosine Associated with Genetic Marker
por: Cojean, Sandrine, et al.
Publicado: (2012)

SUCCESSFUL TREATMENT OF MULTIFOCAL CUTANEOUS LEISHMANIASIS WITH MILTEFOSINE
por: Madke, Bhushan, et al.
Publicado: (2011)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis
por: Voak, Andrew A., et al.
Publicado: (2021)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
por: Wasunna, Monique, et al.
Publicado: (2016)

Nanotechnology: from In Vivo Imaging System to Controlled Drug Delivery
por: Mir, Maria, et al.
Publicado: (2017)

Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model
por: Yuan, Ling, et al.
Publicado: (2013)

Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
por: Bondì, Maria Luisa, et al.
Publicado: (2014)

MDR1 causes resistance to the antitumour drug miltefosine
por: Rybczynska, M, et al.
Publicado: (2001)

Successful Treatment of Disseminated Acanthamoeba sp. Infection with Miltefosine
por: Aichelburg, Alexander C., et al.
Publicado: (2008)

Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major
por: Turner, Kimbra G., et al.
Publicado: (2015)

Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
por: Vincent, Isabel M., et al.
Publicado: (2015)

Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
por: Bastola, Anup, et al.
Publicado: (2019)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
por: Sadowsky, Rachel L., et al.
Publicado: (2022)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021)

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
por: Di Gesù, Roberto, et al.
Publicado: (2018)

Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model
por: Nordin, Noraini, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ippb8dopcit2kesua5q0o825um